Clopidogrel, Aspirin and Proton Pump Inhibition after Percutaneous Valve Implants: An Update
This paper reviews literary evidence on antithrombotic therapies currently employed in TAVR to assess validity and efficacy; duration and modality are also considered. In the absence of firm guidelines and reliable trial results, we analyze current knowledge of interaction between PPI and antithrombotic drugs.
